Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Change in Account Payables (2012 - 2026)

Kamada's (KMDA) quarterly Change in Account Payables came in at $5.4 million in Q2 2026, up 1498.96% on a YoY basis from $335093.7 in Q2 2025, and up 470.54% quarter-over-quarter from -$1.4 million in Q1 2026.

Analysis

Kamada (KMDA) Change in Account Payables (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Change in Account Payables for 15 consecutive years, with $5.4 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Account Payables rose 1498.96% year-over-year to $5.4 million; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (down 46.36% YoY), and the FY2025 full-year result was -$6.9 million, down 660.36% from the prior year.
  • Change in Account Payables improved to $5.4 million in Q2 2026 per KMDA's latest filing, from -$1.4 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $13.7 million in Q3 2022 and bottomed at -$13.6 million in Q1 2022.
  • Historically, Change in Account Payables has averaged -$103444.4 across 5 years, with a median of $125500.0 in 2025.
  • The sharpest annual moves came in 2022 and 2026: Change in Account Payables sank 819.74% in 2022, then jumped 1498.96% in 2026.
  • Over 5 years, Change in Account Payables stood at $1.2 million in 2022, then jumped by 885.52% to $11.4 million in 2023, then gained by 4.73% to $12.0 million in 2024, then sank by 128.17% to -$3.4 million in 2025, then surged by 258.85% to $5.4 million in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered $5.4 million, -$1.4 million, and -$3.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn -
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn -
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn -
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn -
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 7.11 Mn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 5.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.36 Mn
Mar 31, 2026 -1.45 Mn
Dec 31, 2025 -3.37 Mn
Sep 30, 2025 634,000.00
Jun 30, 2025 -383,000.00
Mar 31, 2025 -3.75 Mn
Dec 31, 2024 11.97 Mn
Sep 30, 2024 -5.66 Mn
Jun 30, 2024 3.69 Mn
Mar 31, 2024 -8.79 Mn
Dec 31, 2023 11.43 Mn
Sep 30, 2023 -13.18 Mn
Jun 30, 2023 1.28 Mn
Mar 31, 2023 -6.71 Mn
Dec 31, 2022 1.16 Mn
Sep 30, 2022 13.74 Mn
Jun 30, 2022 5.81 Mn
Mar 31, 2022 -13.65 Mn
Dec 31, 2021 5.19 Mn
Sep 30, 2021 1.59 Mn